Qamar J. Khan

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer”.

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2020.2535

N/A

6.3DataRank · unranked

225 citations

Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain +74 more

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

The Lancet Oncology(2021)10.1016/s1470-2045(21)00589-1

N/A

0.917DataRank · unranked

451 citations

Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze +94 more

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00493-z

N/A

0.900DataRank · unranked

27 citations

Andres Forero‐Torres, Douglas Yee, Christina Yau, Denise M. Wolf, John Park +44 more

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00337-2

N/A

0.510DataRank · unranked

29 citations

Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar +50 more

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

Cancer Cell(2024)10.1016/j.ccell.2024.10.013

N/A

0.416DataRank · unranked

15 citations

Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R. Dry, Hong Shao +22 more

Reconstructing tumor trajectories during therapy through integration of multiple measurement modalities

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.14.426737

N/A

0.165DataRank · unranked

2 citations

Jinfeng Chen, Onalisa Winblad, Anne O’Dea, Priyanka Sharma, Meghna S. Trivedi +13 more

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

npj Breast Cancer(2023)10.1038/s41523-023-00512-7

N/A

0DataRank · unranked

43 citations

Bruce F. Kimler, Rachel Yoder, Kelsey Schwensen, Joshua M. Staley, Qamar J. Khan +11 more

Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

Cancer Cell(2024)10.1016/j.ccell.2024.09.009

N/A

0DataRank · unranked

49 citations

Anton Safonov, Catherine Jones, Enrico Moiso, Jonathan R. Dry, Hong Shao +23 more

Cellular interactions within the immune microenvironment underpins resistance to cell cycle inhibition in breast cancers

Nature Communications(2025)10.1038/s41467-025-56279-x

N/A

0DataRank · unranked

20 citations

Patrick A. Cosgrove, Eric F. Medina, Aritro Nath, Jinfeng Chen, Frederick R. Adler +4 more

Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.09.038

N/A

0DataRank · unranked

1 citations

Roberto Salgado, Julia White, Bruce F. Kimler, Rachel Yoder, Joshua M. Staley +12 more

Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.19.427299

N/A

0DataRank · unranked

0 citations

Jinfeng Chen, Patrick A. Cosgrove, Anne O’Dea, Priyanka Sharma, X. Cynthia +13 more

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00448-4

N/A

0DataRank · unranked

76 citations

Bruce F. Kimler, Joshua M. Staley, Kelsey Schwensen, Yen Y. Wang, Karissa Finke +16 more

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients

Bone Marrow Transplantation(2022)10.1038/s41409-022-01653-2

N/A

0DataRank · unranked

8 citations

Cory Bivona, Ben Liu, Maggie Nelson, Grace Martin, Muhammad Umair Mushtaq +14 more

Bolstering the complex study start-up process at NCI cancer centers using technology

Contemporary Clinical Trials Communications(2022)10.1016/j.conctc.2022.101050

N/A

0DataRank · unranked

3 citations

Sam Pepper, Alexander Alsup, Tara L. Lin, Natalie Streeter, Jeffrey Thompson +4 more

Cancer cells communicate with macrophages to prevent T cell activation during development of cell cycle therapy resistance

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.14.507931

N/A

0DataRank · unranked

3 citations

Patrick A. Cosgrove, Eric Medina Castaneda, Aritro Nath, Jinfeng Chen, Frederick R. Adler +4 more